Vimarsana
Biggest News Aggregation in the World

Page 44 - Work Productivity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Work Productivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Work Productivity Today - Breaking & Trending Today

A four day working week is being trialed in the UK - Vimarsana News

A four day working week is being trialed in the UK

A number of companies in the UK have started trialling a four day working week.

Source: her.ie
Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia - Vimarsana News

Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive data from the Phase 3 multicenter, placebo-controlled, double-blind,...

Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia - Vimarsana News

Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive data from the Phase 3 multicenter, placebo-controlled, double-blind,...

Jazz Pharmaceuticals plc: Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia - Vimarsana News

Jazz Pharmaceuticals plc: Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia

Treatment with Xywav resulted in clinically meaningful improvement in idiopathic hypersomnia symptoms, including excessive daytime sleepiness, sleep inertia and prolonged sleep duration with

Rheumatoid arthritis linked to 30% loss in work productivity 1 year before diagnosis - Vimarsana News

Rheumatoid arthritis linked to 30% loss in work productivity 1 year before diagnosis

Patients developing rheumatoid arthritis can experience a 30% loss in work productivity a full year before the disease clinically manifests, according to data published in Rheumatology.“As the onset of RA is generally during the midst of working life, this constitutes limitations for patients, as well as an economic burden for society,” Cleo Rogier, MD, of Erasmus University Medical

Source: healio.com